Kidney outcomes and prognostic factors in biopsy-proven kidney sarcoidosis: a nationwide multicenter cohort study

Clicks: 1
ID: 323609
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #124 of 125 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 125 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Renal sarcoidosis is a rare manifestation of systemic sarcoidosis. Evidence guiding management remains limited. We aimed to characterize clinical and histopathological features, renal outcomes and predictors of recovery and relapse in patients with renal sarcoidosis. Methods In this retrospective, multicenter observational study across hospitals affiliated with the Spanish Group for the Study of Glomerular Diseases, we included patients with biopsy-confirmed renal sarcoidosis and ≥ 6 months of follow-up. Primary outcomes were renal recovery (defined as > 50% improvement in estimated glomerular filtration rate) and disease relapse (renal or extrarenal). Secondary outcomes included progression to end-stage kidney disease (ESKD) and treatment-related complications. Results Sixty patients with a mean age of 56.8 years were included. Tubulointerstitial involvement predominated (80%), with granulomatous interstitial nephritis in 56.7%, while 23.3% exhibited glomerular disease. Patients with interstitial-only patterns achieved more frequently renal recovery at 12 months compared with those with glomerular involvement (65.9% vs. 20%, P = 0.013). Intravenous corticosteroid pulses were associated with faster renal improvement in our cohort, although it should be interpreted cautiously because of potential indication bias. Higher oral corticosteroid doses, prolonged high-dose exposure, or slower tapering strategies did not improve renal outcomes and were associated with increased complications. Over a median follow-up of 36 months, 38.3% of patients experienced relapse, and 6.7% of patients progressed to ESKD. Conclusions Renal sarcoidosis exhibits heterogeneous presentations but substantial potential for renal recovery, particularly in patients with granulomatous interstitial nephritis. These findings may support further investigation of pathology-informed treatment strategies aimed at reducing corticosteroid exposure. Prospective studies are needed to define optimal treatment strategies.
Reference Key
openalex_W7172421862 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors María Maldonado, Yunayka Diaz-Enamorado, José Enrique Ruiz-Cabello, Ana Cristina Andrade, María Ramírez-Peña, Silvia Vega-Gonzalez, Gabriel González-Suárez, Lucía López-Peláez, Laura Rico-Fernández de Santaella, Joaquín Bande, Cristina Rodríguez-Poza, Juan A. Martín-Navarro, Verónica Ruiz-Garcia, Francisco José Borrego-Utiel, Jonas El Bachouti, Manuel López Mendoza, M Luis, Rebeca García-Agudo, Javier Vian, Raúl Fernández-Prado, Ana Huerta, María Montesa, María Pipa Muñíz, Saulo J. Fernández-Granados, Fernando Caravaca‐Fontán, Gema Fernandez-Juarez, Amir Shabaka
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag246
URL
https://doi.org/10.1093/ckj/sfag246
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.